GSK-5471713 / GSK - LARVOL DELTA

First-Time-in-Human Study of GSK5471713 in Adults With mCRPC (clinicaltrials.gov) - P1/2 | N=54 | Recruiting | Sponsor: GlaxoSmithKline | Not yet recruiting ➔ Recruiting

Enrollment open • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor